Most people with bronchiectasis can safely travel for vacation or business

  It is best to avoid travelling during periods of unstable disease, such as during exacerbations

  People with bronchiectasis should consult their healthcare providers and plan for travel

  People with very severe bronchiectasis (e.g. candidate for lung transplantation, frequent hospitalisation) should be  advised not to travel abroad

  People with bronchiectasis should try to avoid travelling to places with high levels of air pollution

  People with bronchiectasis should try to avoid travelling to places with a high prevalence of NTM (e.g. Hawaii, USA)

  People with bronchiectasis should try to avoid travelling during influenza season

  People with bronchiectasis should consult their healthcare professional regarding staying at high altitudes

  Travelling to high-altitude destinations (above 3050 m/10 000 ft) should be avoided in people with bronchiectasis^#

  People with bronchiectasis should preferably travel to destinations with a nearby bronchiectasis centre

  Health insurance with coverage of deterioration of a chronic condition

  Health insurance with coverage of hospital admission and emergency room visits^#

  Health insurance with coverage of repatriation^#

  When travelling, it is recommended that people with bronchiectasis should continue taking their regular  treatments and make arrangements to take enough medications and equipment for the duration of their travel

  When travelling, people with bronchiectasis should consult their healthcare professional or respiratory  physiotherapist regarding possible alternatives to heavy or large equipment (e.g. nebulisers)

  People with bronchiectasis who suffer frequent pulmonary exacerbations should consult their specialist regarding  carrying antibiotics to be used in case of a pulmonary exacerbation when travelling

  Medications taken for travel should be properly stored according to manufacturer's recommendations (particularly  storage temperature, light exposure)

  Electricity requirements (e.g. for a nebuliser) and cleaning instructions should be known prior to travelling and  proper adaptations, including checking batteries, should be planned

  It is advised that airway clearance and inhalations are performed while waiting at airports before and after flights.  This is best planned ahead and checked with the airport for the best place to do this

  While it is not advised to take cough suppressants for bronchiectasis, it may be considered for long flights where  a cough may be disturbing to other passengers

  It is advised that patients with bronchiectasis carry documentation from the last clinic/hospitalisation visit,  translated into English and preferably also into the language of the country of destination

  A document for travel may be prepared and should include: patient's health status, allergies, chronic bacterial  infections, regular medications and devices used regularly, recommended medications during exacerbation

  It is advised that patients with bronchiectasis carry a translation of a disability card^# (such as a European Union  disability parking card) if eligible and where available

  When travelling in a guided tour, it is advised that people with bronchiectasis should notify the travel company of  their condition

  Oxygen requirements during commercial flights should be predicted before flight

  In people with an FEV₁ <55% pred or oxygen saturation <93% at ambient air, a hypoxia inhalation test should be  performed

  In people with FEV₁ <1.5 L, a hypoxia inhalation test should be performed^#

  When planning travel to destinations between 2000 and 3050 m, considerations as for commercial flights should  be made

  It is recommended that people with bronchiectasis seek advice for travellers and follow recommended  immunisations for the destination

  Recommended medications while travelling (such as for the prevention of malaria) should be checked for  interactions with regular treatments and with treatments during exacerbations

  It is recommended that people with bronchiectasis should be stable prior to travelling, if symptoms typical for an  exacerbation develop shortly before travelling, treatment should be started and travel postponed if possible

  People with severe bronchiectasis and chronic Pseudomonas sp. infection may be advised to receive treatment  with an intravenous antibiotic course shortly before travelling to prevent an exacerbation while away

  It is recommended that people with bronchiectasis should use sun protection while using medications that  increase photosensitivity (e.g. ciprofloxacin, doxycycline)

  It is recommended that people with bronchiectasis take measures to avoid dehydration while in a hot climate

  It is advised that people with bronchiectasis maintain general measures of hygiene to prevent cross-infection:  hand hygiene, wearing face masks in crowded places

  It is recommended that all people with bronchiectasis refrain from SCUBA diving

  It may be safe for people with bronchiectasis to SCUBA dive if they are asymptomatic (no sputum or shortness of  breath at the time of diving) and lung function is normal (FEV₁ and peak expiratory flow should both be  >80% pred, FEV₁/forced vital capacity >75%)

  It is recommended that people with bronchiectasis should be aware of their own limitations to strenuous activities  and limit their participation in such activities accordingly. This refers to sports including hiking, swimming and  snorkelling, but also less strenuous activities such as short walks uphill and climbing stairs

  Prior to travel, people with bronchiectasis should be advised on increasing airway clearance if suffering an  exacerbation while away

  Prior to travel, people with bronchiectasis should be advised when to take antibiotics, including a recommendation  for an oral antibiotic, dose and duration

  People with bronchiectasis should be advised when and where to seek medical care at their destination